Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Endocrinology | Rheumatology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Royce Laboratories
Approval Status: Approved April 1997
Treatment Area: rheumatoid arthritis
Etodolac Tablets USP, 400mg, have been approved for the
treatment of rheumatoid arthritis. Etodolac is the generic
equivalent of Wyeth Ayerst’s Lodine Tablets. Etodolac was earlier
approved for treating osteoarthritis and managing pain.
The safety and efficacy for treating rheumatoid arthritis was
established in a 3 year double-blind, mulitcenter trial of 1446
patients. In the study 1000mg/day was effective and well tolerated.
The recommended starting dose is 600-1000mg/day, divided into two
or three doses.
